- Review
- Open access
- Published:
Arterial structure and function in end-stage renal disease
Artery Research volume 1, pages 79–88 (2007)
Summary
Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with end-stage renal disease (ESRD). The risk of CVD disease in these patients appears to be far greater than in the general population and even after the stratification for age, gender, race and the presence or absence of diabetes, cardiovascular mortality in dialysis patients is about 10 to 20 times higher than in the general population. As a diagnostic categorie, CVD includes two principal conditions, i.e., cardiac complications stricto sensu, and vascular complications. These two complications are interrelated and arterial alterations can be the primary reason for the development of cardiac complications. Macrovascular disease develops rapidly in ESRD patients and is responsible for the high incidence of congestive heart failure, left ventricular hypertrophy (LVH), ischemic heart disease, sudden death, cerebrovascular accidents and peripheral artery diseases. Although the most frequent cause of these complications is occlusive lesions due to atheromatous plaques, many complications arise in ESRD patients in the absence of clinically significant atherosclerotic disease. Atherosclerosis, disease characterized by the presence of plaques, represents only one form of structural response to metabolic and hemodynamic alterations which interfere with the “natural” process of aging. The spectrum of arterial alterations in ESRD is broader, including large artery remodeling and changes in viscoelastic properties of arterial walls. The consequences of these alterations are different from those attibuted to plaques. While atheromatous lesions alter principally the conduit function of arteries and perfusion of tissue and organs downstream the lesions, non-atheromatous remodelling result principally in changes in dampening function of arteries, characterized by stiffening of arterial walls and with deleterious effects on the left ventricle and coronary perfusion. Arterial stiffening in ESRD patients is multifactorial at origin with extensive arterial calcifications as an important covariate.
References
USRD. US Renal Data System. Annual Report. Bethesda, MD, The National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 1998;32(Suppl. 1):S81–88.
London GM, Guérin AP, Marchais SJ, Pannier B, Safar ME, Day M, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996;50:600–8.
Gibbons GH, Dzau V. The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431–8.
Hull SSJ, Kaiser L, Jaffe MD, Sparks HVJ. Endothelium-dependent flow-induced dilatation of canine femoral and saphenous arteries. Blood Vessel 1986;23:183–98.
Mulvany M. The structure of the resistance vasculature in essential hypertension. J Hypertens 1987;5:129–36.
Zarins CK, Zatine MA, Giddens DP, Ku DN, Glagov S. Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg 1987;5:413–20.
Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Eng J Med 1987;316:1371–5.
Girerd X, London G, Boutouyrie P, Mourad JJ, Laurent S, Safar M. Remodelling of radial artery and chronic increase in shear stress. Hypertension 1996;27(Part 2):799–803.
Dobrin PB, Littooy FN, Endean ED. Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery 1989;105:393–400.
Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995;75:519–60.
Nichols WW, O’Rourke MF. Vascular impedance, McDonald’s blood flow in arteries: theoretical, experimental and clinical principles. 4th ed. London: Edward Arnold; 1998.
Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilatator response to increased flow in vivo. Hypertension 1986;8:37–44.
Traub O, Berk BC. Laminar shear stress: Mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998;18:677–85.
Moncada S, Palmer RMJ, Higgs A. Nitric Oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43: 109–42.
Cooke JP, Rossitch E, Andon N, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991;88:1663–71.
Kolle A, Sun D, Huang A, Kaley G. Corelease of nitric oxide and prostaglandins mediates flow-dependent dilatation of rat gracilis muscle arterioles. Am J Physiol 1994;267:H326–32.
Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993;264:H150–6.
Walpola PL, Gotlieb AI, Cybulsk M, Langille BL. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol 1995;15:2–10.
Chiu JJ, Wung BS, Shyy JYJ, Hsieh HJ, Wang DL. Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 1997;17:3570–7.
Hsieh HJ, Li NQ, Frangos JA. Shear-induced platelet-derived growth factor gene expression in human endothelial cells is mediated by protein kinase C. J Cell Physiol 1992;150:552–8.
Hassid A, Arabshahi H, Bourcier T, Dhaunsi GS, Matthews C. Nitric oxide selectively amplifies FGF-2 induced mitogenesis in primary rat aortic smooth muscle cells. Am J Physiol 1994; 267:H1040–8.
Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of autocrine PDGF loop. Cell 1990;63: 515–24.
Bassiouny HS, Song RH, Hong XF, Singh A, Kocharyan H, Glagov S. Flow regulation of 72-kD collagenase IV (MMP-2) after experimental arterial injury. Circulation 1998;98:157–63.
Langille BL, O’Donnell F. Reductions in arterial diameters produced by chronic decrease in blood flow are endothelium-dependent. Science 1986;231:405–7.
Dzau VJ. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. Curr Opin Nephrol Hypertens 1993;2:27–32.
Bassiouny HS, Zarins CK, Kadowaki MH, Glagov S. Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vas Surg 1994;19:426–34.
Moore Jr JE, Xu C, Glagov S, Zarins CK, Ku DN. Fluid wall shear stress measurements in a model of the human abdominal aorta: oscillatory behavior and relationship to atherosclerosis. Atherosclerosis 1994;110:225–40.
Sprague EA, Steinbach BL, Nerem RM, Schwartz CJ. Influence of a laminar steady-state fluid-imposed wall shear stress on the binding, internalization, and degradation of low-density lipoproteins by cultured arterial endothelium. Circulation 1987; 76:648–56.
Kaiser D, Freyberg MA, Friedl P. Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. Biochem Biophys Res Commun 1997;231:586–91.
Barbee KA, Davies PF, Lal R. Shear stress-induced reorganization of the surface topography of living endothelial cells imaged by atomic force microscopy. Circ Res 1994;74:163–71.
Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 2005;85:9–23.
Yamawaki H, Pan S, Lee RT, Berk BC. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 2005;115:733–8.
Tricot O, Mallat Z, Heymes C, Belmin J, Leseche G, Tedgui A. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 2000; 101:2450–3.
O’Rourke MF. Mechanical principles in arterial disease. Hypertension 1995;26:2–9.
Krooker EJ, Wood EH. Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man. Circ Res 1955;3:623–32.
Karamanoglu M, O’Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993;14:160–7.
Chen CH, Nevo E, Fetics B, Pak PH, Yin FCP, Maughan L, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997;95:1827–36.
Latham RD, Westerhof N, Sipkema P, Rubal BJ, Reuderink P, Murgo JP. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures. Circulation 1985;72:1257–69.
Bramwell JV, Hill AV. Velocity of transmission of the pulse wave and elasticity of arteries. Lancet 1922;1:891–2.
Avolio AO, Chen SG, Wang RP, Cl Zhang, Li MF, O’Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983;68:50–8.
Nichols WW, Avolio AP, Kelly RP, O’Rourke MF. Effects of age and of hypertension on wave travel and reflections. In: O’Rourke M, Safar M, Dzau V, editors. Arterial vasodilatation: mechanisms and therapy. London: Edward Arnold; 1993. p. 23–40.
O’Rourke MF, Kelly RP. Wave reflections in systemic circulation and its implications in ventricular function. J Hypertens 1993; 11:327–37.
Kelly R, Hayward C, Avolio A, O’Rourke MF. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 1989;80:1652–9.
London GM, Yaginuma T. Wave reflections: clinical and therapeutic aspects. In: Safar ME, O’Rourke MF, editors. The arterial system in hypertension. Dordrecht: Kluwer Academic Publishers; 1993. p. 221–37.
London GM, Guerin AP, Pannier B, Marchais SJ, Benetos A, Safar ME. Increased systolic pressure in chronic uremia: Role of arterial wave reflections. Hypertension 1992;20:10–9.
Buckberg GD, Towers B, Paglia DE, Mulder DG, Maloney JV. Sub-endocardial ischemia after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1972;64:669–87.
Watanabe H, Ohtsuka S, Kakihana M, Sugishita Y. Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol 1993;21:1497–506.
Chang KC, Tseng YZ, Kuo TS, Chen HI. Impaired left ventricular relaxation and arterial stiffness in patients with essential hypertension. Clin Sci 1994;87:641–7.
Virmani R, Avolio AP, Mergner WJ, Robinowitz R, Herderick EE, Cornhill JF, et al. Effects of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Am J Pathol 1991;139:1119–29.
Vaitkevicius PV, Fleg JL, Engel JH, O’Connor FC, Wright JG, Lakatta LE, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993;88(Part 1): 1456–62.
Lindner A, Charra B, Sherrard D, Scribner BM. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697–702.
Pascazio L, Bianco F, Giorgini A, Galli G, Curri G, Panzetta G. Echo color Doppler imaging of carotid vessels in hemodialysis patients: evidence of high levels of atherosclerotic lesions. Am J Kidney Dis 1996;28:713–20.
Rossi A, Bonfante L, Giacomini A, Calabro A, Rossi G, Saller A, et al. Carotid artery lesions in patients with nondiabetic chronic renal failure. Am J Kidney Dis 1996;27:58–66.
Joki N, Nakamura R, Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997;12:718–23.
Savage T, Clarke AL, Giles M, Tomson CRV, Raine AEG. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant 1998;13:2004–12.
Vincenti F, Amend WJ, Abele J, Feduska NJ, Salvatierra Jr O. The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 1980;68:363–9.
Samijo SK, Barkhuysen R, Willigers JM, Leunissen KM, Ledoux LA, Kitslaar PJ, et al. Wall shear stress assessment in common carotid artery of end-stage renal failure patients. Nephron 2002;92:557–63.
Verbeke FH, Agharazii M, Boutouyrie P, Pannier B, Guérin AP, London GM. Local shear stress and brachial artery functions in end-stage renal disease. J Am Soc Nephrol; 2007.
Boulanger CM, Amabile N, Guérin AP, Pannier B, Leroyer AS, Nguyen C, et al. In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension 2007;49:1–7.
Barenbrock M, Spieker C, Laske V, Heidenreich S, Hohage H, Bachmann J, et al. Studies of the vessel wall properties in he-modialysis patients. Kidney Int 1994;45:1397–400.
London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F, et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int 1990;37:137–42.
London GM, Drüeke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997;51:1678–95.
Mourad JJ, Girerd X, Boutouyrie P, Laurent S, Safar ME, London GM. Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 1997;30:1425–30.
Briet M, Bozec E, Laurent S, Fassot C, London GM, Jacquot C, et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int 2002;69:350–7. 2006.
Dammers R, Tordoir JHM, Welten RJ, Kitslaar PJEHM, Hoeks APG. The effect of chronic flow changes on brachial artery diameter and shear stress in arteriovenous fistulas for hemodialysis. Int J Artif Organs 2002;25:124–8.
Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 1995;48:820–6.
Hayoz D, Rutschmann B, Perret F, Niederberger M, Tardy Y, Mooser V, et al. Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 1992;20:1–6.
Laurent S, Girerd X, Mourad JJ, Lacolley P, Beck L, Boutouyrie P, et al. Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscler Thromb 1994;14:1223–31.
Ibels LS, Alfrey AL, Huffer WE, Craswell PW, Anderson JT, Weil R. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 1979;66:790–6.
Amann K, Neusüß R, Ritz E, Irzyniec T, Wiest G, Mall G. Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens 1995;8:409–17.
Amann K, Wolf B, Nichols C, Törnig J, Schwartz U, Zeier M, et al. Aortic changes in experimental renal failure: Hyperplasia or hypertrophy of smooth muscle cells? Hypertension 1997;29: 770–5.
Nishizawa Y, Shoji T, Kawagishi T, Morii H. Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. Kidney Int 1997; 52(Suppl. 2):S90–2.
Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RB, Salusky I. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478–83.
Blacher J, Guérin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938–42.
Guérin AP, London GM, Marchais SJ, Métivier F. Arterial stiffening and vascular calcification in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014–21.
Haydar AA, Covic A, Colhoun H, Rubens M, Goldsmith DJ. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 2004;65:1790–4.
Marchais SJ, Guérin AP, Pannier BM, Lévy BI, Safar ME, London GM. Wave reflections and cardiac hypertrophy in chronic uremia: influence of body size. Hypertension 1993; 22:876–83.
Blacher J, Guérin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434–9.
Shoji T, Emoto M, Shinohara K, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001;12:2117–24.
Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002;39:10–5.
Laurent S, Katsahian S, Fassot C, Tropeano A-I, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003;34: 1203–6.
Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998;32:570–4.
Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension; 2006.
Girerd X, Giannattassio C, Moulin C, Safar M, Mancia G, Laurent S. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol 1998;31:1063–73.
London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994;90:2786–96.
Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal disease. Circulation 2001;103:987–92.
Wilson PWF, Kauppila LI, O’Donnell CJ, Kiel PD, Hannan M, Polak JM, et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001;103:1529–34.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an open access article distributed under the CC BY-NC license https://doi.org/creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pannier, B., Guérin, A.P., Marchais, S.J. et al. Arterial structure and function in end-stage renal disease. Artery Res 1, 79–88 (2007). https://doi.org/10.1016/j.artres.2007.06.001
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.artres.2007.06.001